These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 9392140)

  • 1. [Insulin promoter factor-1].
    Suzuki K; Ishihara H; Shibasaki Y
    Nihon Rinsho; 1997 Oct; 55 Suppl():409-13. PubMed ID: 9392140
    [No Abstract]   [Full Text] [Related]  

  • 2. A newly discovered role of transcription factors involved in pancreas development and the pathogenesis of diabetes mellitus.
    Habener JF; Stoffers DA
    Proc Assoc Am Physicians; 1998; 110(1):12-21. PubMed ID: 9460079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IPF1, a homeodomain protein with a dual function in pancreas development.
    Jonsson J; Ahlgren U; Edlund T; Edlund H
    Int J Dev Biol; 1995 Oct; 39(5):789-98. PubMed ID: 8645563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Insulin promotor factor I (IPF-I) is an essential factor during development of the pancreas].
    Z Gastroenterol; 1995 Apr; 33(4):225-6. PubMed ID: 7793123
    [No Abstract]   [Full Text] [Related]  

  • 5. Pancreas development in the chick embryo.
    Kim SK; Hebrok M; Melton DA
    Cold Spring Harb Symp Quant Biol; 1997; 62():377-83. PubMed ID: 9598372
    [No Abstract]   [Full Text] [Related]  

  • 6. The cut-homeodomain transcriptional activator HNF-6 is coexpressed with its target gene HNF-3 beta in the developing murine liver and pancreas.
    Rausa F; Samadani U; Ye H; Lim L; Fletcher CF; Jenkins NA; Copeland NG; Costa RH
    Dev Biol; 1997 Dec; 192(2):228-46. PubMed ID: 9441664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-promoter-factor 1 is required for pancreas development in mice.
    Jonsson J; Carlsson L; Edlund T; Edlund H
    Nature; 1994 Oct; 371(6498):606-9. PubMed ID: 7935793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory factor linked to late-onset diabetes?
    Dutta S; Bonner-Weir S; Montminy M; Wright C
    Nature; 1998 Apr; 392(6676):560. PubMed ID: 9560151
    [No Abstract]   [Full Text] [Related]  

  • 9. Pancreatic duodenal homeobox factor-1 and diabetes mellitus type 2 (review).
    Al-Quobaili F; Montenarh M
    Int J Mol Med; 2008 Apr; 21(4):399-404. PubMed ID: 18360684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pbx1 inactivation disrupts pancreas development and in Ipf1-deficient mice promotes diabetes mellitus.
    Kim SK; Selleri L; Lee JS; Zhang AY; Gu X; Jacobs Y; Cleary ML
    Nat Genet; 2002 Apr; 30(4):430-5. PubMed ID: 11912494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence.
    Stoffers DA; Zinkin NT; Stanojevic V; Clarke WL; Habener JF
    Nat Genet; 1997 Jan; 15(1):106-10. PubMed ID: 8988180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [What the developmental biology in pancreatogenesis brought us: insights in human diseases and possible application to the regenerative therapy for diabetes].
    Kawaguchi Y
    Tanpakushitsu Kakusan Koso; 2007 Oct; 52(12):1406-12. PubMed ID: 17926547
    [No Abstract]   [Full Text] [Related]  

  • 13. Developmental biology. In embryos, pancreas and liver reach full size in different ways.
    Couzin J
    Science; 2007 Feb; 315(5812):587. PubMed ID: 17272695
    [No Abstract]   [Full Text] [Related]  

  • 14. Reduced PDX-1 expression impairs islet response to insulin resistance and worsens glucose homeostasis.
    Brissova M; Blaha M; Spear C; Nicholson W; Radhika A; Shiota M; Charron MJ; Wright CV; Powers AC
    Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E707-14. PubMed ID: 15562255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular biology. HNFs--linking the liver and pancreatic islets in diabetes.
    Kulkarni RN; Kahn CR
    Science; 2004 Feb; 303(5662):1311-2. PubMed ID: 14988544
    [No Abstract]   [Full Text] [Related]  

  • 16. Transcription factor cycling on the insulin promoter.
    Barrow J; Hay CW; Ferguson LA; Docherty HM; Docherty K
    FEBS Lett; 2006 Jan; 580(2):711-5. PubMed ID: 16412423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pancreatic development and differentiation factors of beta cell].
    Ogata T; Kojima I
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():347-53. PubMed ID: 12238071
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of PDX-1 and MafA as a potential therapeutic target for diabetes.
    Kaneto H; Miyatsuka T; Fujitani Y; Noguchi H; Song KH; Yoon KH; Matsuoka TA
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S127-37. PubMed ID: 17449132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of the STAT4 signaling pathway protects from autoimmune diabetes while retaining antiviral immune competence.
    Holz A; Bot A; Coon B; Wolfe T; Grusby MJ; von Herrath MG
    J Immunol; 1999 Nov; 163(10):5374-82. PubMed ID: 10553062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a single nucleotide insertion polymorphism in the upstream region of the insulin promoter factor-1 gene: an association study with diabetes mellitus.
    Yamada K; Yuan X; Ishiyama S; Ichikawa F; Kohno S; Shoji S; Hayashi H; Nonaka K
    Diabetologia; 1998 May; 41(5):603-5. PubMed ID: 9628281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.